Feno and blood eosinophils as biomarkers in predicting asthma exacerbations
With advances in new therapies that target airway inflammation, there is an urgent need for accurate and easy-to-use biomarkers to predict asthma exacerbations and likely patient responses to treatment. Blood and sputum eosinophilia are used to predict the response of patients with asthma to steroi...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
BMJ Publishing Group
2017
|